Ozempic Alternatives You Can Get Online in 2026: GLP-1 Options, Pricing, and What to Know

Important: GLP-1 receptor agonists are prescription medications with significant effects and side effects. This article is educational and does not constitute medical advice. These medications should only be used under the supervision of a qualified healthcare provider with appropriate medical evaluation and monitoring. Do not start, stop, or change any medication without consulting your physician.

Ozempic (semaglutide 0.25mg-1mg) was approved by the FDA for type 2 diabetes management. Wegovy (semaglutide 2.4mg) was approved for chronic weight management. Mounjaro (tirzepatide) was approved for diabetes. Zepbound (tirzepatide) was approved for weight management. And in between these FDA-approved pathways, a massive market of compounded semaglutide and telehealth weight loss platforms has emerged.

The demand is enormous. Ozempic and Wegovy have been in chronic shortage since 2022, with the FDA's Drug Shortage Database listing semaglutide as in limited supply. This shortage has driven millions of patients toward telehealth platforms offering compounded semaglutide (a non-branded version made by compounding pharmacies while the drug is on the FDA shortage list) at prices significantly below the branded medications.

But the landscape is confusing and sometimes dangerous. Prices range from $200 to $1,500+ per month. Some platforms provide thorough medical oversight. Others are glorified prescription mills. The compounded semaglutide market has quality concerns that patients need to understand.

We evaluated five of the most established telehealth platforms offering GLP-1 and GLP-1-adjacent weight loss treatments on medical oversight quality, medication access, pricing transparency, monitoring protocols, and patient safety.

Our Top Picks

• Best Overall: Ro (Body Program) -- Most balanced combination of medical oversight, GLP-1 access, pricing, and platform quality
• Best for Comprehensive Care: Calibrate -- Physician-supervised metabolic health program with the most thorough lifestyle component
• Best Value for Compounded Semaglutide: Henry Meds -- Lowest pricing for compounded semaglutide with medical oversight
• Best Platform Experience: Hims/Hers -- Sleekest digital experience with multiple weight loss treatment options
• Best for Behavioral Support: Found -- Strongest focus on behavioral and psychological aspects of weight management alongside medication

Understanding GLP-1 Options in 2026

Brand-Name FDA-Approved Medications

These list prices are before insurance. With insurance coverage (which varies enormously by plan), out-of-pocket costs can range from $25-$500/month. Without insurance, most patients cannot afford branded GLP-1 medications.

Compounded Semaglutide

While semaglutide remains on the FDA Drug Shortage List, compounding pharmacies can legally produce compounded semaglutide under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. This is the primary way that telehealth platforms offer semaglutide at $200-$500/month rather than $900-$1,350/month.

The critical caveat: Compounded medications are not FDA-approved. They are not subject to the same manufacturing standards, quality testing, or bioequivalence requirements as branded medications. The quality depends entirely on the compounding pharmacy producing them. Most reputable pharmacies produce safe, effective compounded semaglutide. Some do not.

In 2023-2024, the FDA issued warnings about adverse events linked to products marketed as semaglutide obtained from non-FDA-regulated sources. These included products containing salt forms of semaglutide (semaglutide sodium, semaglutide acetate) that are chemically different from the active ingredient in Ozempic/Wegovy.

What to verify: Ask your telehealth platform which 503B compounding pharmacy produces their semaglutide. Verify the pharmacy is FDA-registered. Ask whether the semaglutide is the base form (same as branded) or a salt form. This is not optional due diligence -- it is essential safety information.

The FDA Shortage Dynamic

The availability of compounded semaglutide is legally tied to the FDA shortage designation. If Novo Nordisk resolves the Ozempic/Wegovy shortage and the FDA removes semaglutide from the shortage list, compounding pharmacies may no longer be permitted to produce it. This would disrupt the compounded semaglutide market significantly.

As of early 2026, semaglutide remains on the FDA shortage list, and compounding continues. But this could change, and patients should be aware of the regulatory risk.

The Science: What GLP-1 Medications Actually Do

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone that:

1. Stimulates insulin secretion (glucose-dependent) -- helping lower blood sugar after meals
2. Suppresses glucagon release -- reducing liver glucose production
3. Slows gastric emptying -- food stays in the stomach longer, increasing satiety
4. Acts on brain appetite centers -- reducing hunger and food reward signals

The weight loss effect comes primarily from reduced appetite and caloric intake. Patients on GLP-1 medications consistently report dramatically reduced hunger, fewer food cravings, and earlier satiety at meals. This is a genuine pharmacological effect, not willpower.

The Clinical Evidence

The evidence for GLP-1 medications in weight management is among the strongest in obesity medicine:

• STEP 1 Trial (Wilding et al., 2021, NEJM): Semaglutide 2.4mg produced average weight loss of 14.9% of body weight (vs. 2.4% placebo) over 68 weeks. One-third of participants lost more than 20% of body weight.

• SURMOUNT-1 Trial (Jastreboff et al., 2022, NEJM): Tirzepatide (Mounjaro/Zepbound) at the highest dose (15mg) produced average weight loss of 22.5% of body weight over 72 weeks. This is approaching the results of bariatric surgery.

• STEP 5 Trial (Garvey et al., 2022, Nature Medicine): 2-year data showing semaglutide maintained weight loss of ~15% at 104 weeks, demonstrating durability of effect with continued treatment.

The Weight Regain Problem

The biggest concern with GLP-1 medications is what happens when you stop. The STEP 1 Trial Extension (Wilding et al., 2022, Diabetes, Obesity and Metabolism) showed that participants who discontinued semaglutide after 68 weeks regained approximately two-thirds of the lost weight within one year.

This means GLP-1 medications are likely a long-term or indefinite commitment for maintaining weight loss. The medication treats the biological drivers of obesity (dysregulated appetite signaling) -- when the treatment stops, the biological drivers return. This is analogous to blood pressure medication: it works while you take it.

This has enormous implications for cost, side effect exposure, and treatment planning. Any prescriber should discuss this with you explicitly.

What to Look For in a GLP-1 Telehealth Platform

Medical Oversight Quality

At minimum, your prescriber should review your medical history, current medications, BMI, and relevant lab work before prescribing a GLP-1. Better platforms order metabolic bloodwork (fasting glucose, HbA1c, lipid panel, kidney/liver function) and perform ongoing monitoring. Any platform that prescribes after a 5-minute questionnaire without labs is cutting corners.

Compounding Pharmacy Quality

Ask which compounding pharmacy produces the medication. Verify the pharmacy is FDA-registered under section 503B (outsourcing facilities with more stringent requirements) or state-licensed under 503A. Ask about testing and quality assurance practices. This is the most important safety question in the compounded GLP-1 space.

Dosing Protocol

GLP-1 medications require careful dose titration -- starting at a low dose and gradually increasing over weeks to months. This reduces GI side effects (nausea, vomiting, diarrhea) and allows your body to adapt. Any platform that starts you at the maximum dose without titration is practicing irresponsibly.

Side Effect Management

GLP-1 side effects are common, especially during titration. Nausea affects 40-50% of patients. Vomiting, diarrhea, and constipation are also common. More serious but rare side effects include pancreatitis, gallbladder disease, and (in animal studies) thyroid C-cell tumors. Your prescriber should actively manage side effects and adjust dosing accordingly.

Detailed Platform Reviews

1. Ro (Body Program) -- Best Overall

Price: $145-$499/month (varies by medication) | Medications: Compounded semaglutide, branded GLP-1s (insurance-dependent) | Provider: Licensed physicians | Labs: Required (can use own or Ro-ordered) | Monitoring: Regular check-ins, dose adjustments

Ro (formerly Roman) has built one of the most comprehensive telehealth weight loss programs available. The Body Program combines GLP-1 medication access with metabolic coaching, regular physician check-ins, and systematic dose titration.

The medical oversight is strong. Physicians review medical history, current medications, and lab work before prescribing. Dose titration follows established protocols, and providers are available for side effect management and dose adjustments. The platform tracks weight, medication adherence, and side effects over time.

Ro works with established 503B compounding pharmacies for compounded semaglutide and can also prescribe branded medications (Wegovy, Zepbound) for patients with insurance coverage. This flexibility means your treatment is not locked into compounded-only access.

The pricing structure is tiered: compounded semaglutide starts at approximately $145/month on longer-term plans, while branded medications with insurance are priced at your copay level. All-in costs including medication, consultations, and monitoring are transparent.

Pros:

• Strong medical oversight with physician-led care
• Both compounded and branded GLP-1 access
• Systematic dose titration protocols
• Transparent, tiered pricing
• Integrated tracking and monitoring
• Large platform with broad physician network

Cons:

• Compounded semaglutide quality depends on pharmacy partner
• $145-$499/month is a significant ongoing cost
• Branded medications require insurance for affordability
• Lifestyle coaching component is lighter than Calibrate
• Wait times for physician appointments during demand spikes

Best For: People who want the best balance of medical oversight, medication access, and platform quality.

2. Calibrate -- Best for Comprehensive Care

Price: $135-$199/month (12-month program) | Medications: GLP-1 access (compounded and branded) | Provider: Board-certified physicians + certified coaches | Labs: Required metabolic panel | Monitoring: Regular physician visits + coaching sessions

Calibrate takes the most holistic approach to GLP-1 therapy. Rather than simply prescribing medication, Calibrate's program addresses the four pillars of metabolic health: food, sleep, exercise, and emotional health. The physician manages medication. The coach works with you on the lifestyle factors that medication alone does not change.

This integrated approach matters because the weight regain data is clear: medication without behavior change produces medication-dependent weight loss. Calibrate's hypothesis is that building sustainable habits during the medication window creates a foundation for maintained weight loss even if medications are reduced or discontinued. This is a sound hypothesis, though long-term data specific to Calibrate's program is still being collected.

The physician component includes metabolic bloodwork, medication prescribing and titration, regular medical reviews, and lab monitoring. The coaching component includes video sessions, a structured curriculum, and accountability check-ins.

Pros:

• Most comprehensive lifestyle component alongside medication
• Physician-supervised with required metabolic bloodwork
• Addresses food, sleep, exercise, and emotional health
• Structured 12-month program with clear milestones
• Evidence-informed approach to behavior change

Cons:

• $135-$199/month for 12 months ($1,620-$2,388 total) -- medication often additional
• 12-month commitment required
• Medication cost may be on top of program fee (insurance-dependent)
• Not for those who want medication only without the coaching
• Program structure may feel rigid for some

Best For: People who want the most thorough, physician-supervised weight loss program combining medication with structured lifestyle change.

3. Henry Meds -- Best Value for Compounded Semaglutide

Price: $199-$349/month (medication included) | Medications: Compounded semaglutide, compounded tirzepatide | Provider: Licensed physicians | Labs: Recommended, not always required | Monitoring: Provider check-ins, dose adjustments

Henry Meds has positioned itself as the value option in the compounded GLP-1 space. Their pricing bundles physician consultation, medication, supplies, and shipping into a single monthly fee. For patients without insurance who need the lowest all-in cost for medically supervised GLP-1 therapy, Henry Meds is competitive.

The medical process is streamlined: online consultation, medical history review, and (if appropriate) prescription with home delivery. Dose titration follows standard protocols, and providers are available for adjustments.

The concern with value-positioned platforms is always the depth of medical oversight. Henry Meds' consultations are efficient but may be shorter than Ro's or Calibrate's. Lab requirements are less stringent than Calibrate. For straightforward cases (otherwise healthy patients with BMI 30+ seeking weight management), this efficiency may be appropriate. For complex cases (diabetes, multiple medications, cardiovascular risk factors), more thorough oversight is warranted.

Pros:

• Competitive all-inclusive pricing
• Both compounded semaglutide and tirzepatide available
• Medication, consultation, and shipping bundled
• Fast onboarding process
• No separate lab or consultation fees on most plans

Cons:

• Less clinical depth than Ro or Calibrate
• Lab requirements are less stringent
• Compounding pharmacy quality varies (ask which pharmacy is used)
• Lifestyle coaching is minimal
• Newer platform with less track record

Best For: Budget-conscious patients who want medically supervised compounded GLP-1 access at the lowest price point.

4. Hims/Hers -- Best Platform Experience

Price: $199-$499/month | Medications: Compounded semaglutide, other weight loss options | Provider: Licensed physicians, NPs, PAs | Labs: Varies by plan | Monitoring: Regular provider check-ins

Hims (for men) and Hers (for women) have the slickest digital experience in telehealth. The app is beautifully designed, the onboarding is smooth, and the brand positioning is premium lifestyle rather than clinical medical.

The weight loss program offers compounded semaglutide alongside other options (oral medications, lifestyle coaching). The platform's strength is user experience: medication tracking, refill management, provider messaging, and progress tracking are all integrated into a polished app.

The medical quality is adequate. Licensed providers evaluate patients, prescribe appropriately, and monitor treatment. The depth of clinical interaction is not at the level of Calibrate or Marek Health, but it exceeds the bare minimum. Hims/Hers has invested in physician quality following earlier industry criticism about overly casual prescribing on DTC platforms.

Pros:

• Best app and user experience in the category
• Established brand with large platform
• Multiple treatment options beyond GLP-1
• Smooth onboarding and medication management
• Good provider communication tools

Cons:

• Premium pricing for what is partly brand premium
• Clinical depth is average, not exceptional
• Compounded medication quality depends on pharmacy partner
• Marketing-forward positioning can overshadow clinical substance
• Subscription management and cancellation have drawn complaints

Best For: People who value a polished digital experience and want their weight loss treatment managed through a premium platform.

5. Found -- Best for Behavioral Support

Price: $99-$349/month | Medications: GLP-1 access, other weight loss medications | Provider: Licensed physicians + behavioral health coaches | Labs: Recommended | Monitoring: Regular coaching sessions + provider check-ins

Found takes a behavior-first approach to medical weight loss. While medication is part of the program, the core thesis is that lasting weight management requires understanding and changing the behavioral, psychological, and environmental factors that drive overeating. Medication creates a window of reduced appetite during which new habits can be built.

The behavioral coaching is more substantive than what Hims or Henry Meds offer. Coaches work with you on meal planning, emotional eating patterns, movement habits, and environmental modifications (how your home, kitchen, and social environment influence eating behavior).

The physician component handles medication prescribing and monitoring. Found's treatment options include GLP-1 medications, bupropion/naltrexone, metformin, and other evidence-based weight loss medications -- giving prescribers flexibility to tailor treatment to your specific situation.

Pros:

• Strongest behavioral and psychological component
• Multiple medication options (not GLP-1 only)
• Coaching addresses root causes of overeating
• Flexible treatment approach based on individual needs
• More affordable starting price than some competitors

Cons:

• Coach quality varies
• Behavioral approach requires active engagement (not just medication compliance)
• GLP-1 access may have wait times during high demand
• Less medically thorough than Calibrate
• Newer platform with evolving program structure

Best For: People who want to address the behavioral and psychological aspects of weight management alongside medication.

Comparison Table

Safety Considerations

Common Side Effects (GLP-1 Medications)

Side effects are common, especially during dose titration:

• Nausea: 40-50% of patients (usually improves over weeks)
• Vomiting: 15-25%
• Diarrhea: 15-30%
• Constipation: 10-20%
• Injection site reactions: 5-10%

Most GI side effects diminish after 4-8 weeks as the body adapts. Slow dose titration significantly reduces their severity.

Serious but Rare Side Effects

• Pancreatitis: Rare but reported. Symptoms include severe abdominal pain radiating to the back. Seek immediate medical attention.
• Gallbladder disease: Rapid weight loss increases gallstone risk. GLP-1 medications may compound this.
• Thyroid C-cell tumors: Observed in rodents at high doses. Not confirmed in humans, but GLP-1 medications carry a boxed warning and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.

Contraindications

GLP-1 medications should not be used by:

• Patients with personal or family history of medullary thyroid carcinoma or MEN2
• Patients with a history of pancreatitis
• Pregnant or breastfeeding women
• Patients with severe GI disease (gastroparesis)

This is not a complete list. Discuss your full medical history with your prescriber.

---

Related Reading

• Tirzepatide vs Semaglutide -- comparing the two top GLP-1 medications
• Telehealth Semaglutide Providers 2026 -- where to get semaglutide online
• Best Telehealth Weight Loss Programs 2026 -- the full weight loss landscape
• Retatrutide Guide -- the triple-agonist that could change everything
• Best Berberine Supplements 2026 -- a natural GLP-1-like supplement

---

FAQ

Is compounded semaglutide the same as Ozempic?

Compounded semaglutide contains the same active pharmaceutical ingredient (semaglutide) as Ozempic, but it is not produced by Novo Nordisk and is not FDA-approved. The quality, potency, and sterility depend on the compounding pharmacy. Reputable 503B pharmacies produce compounded semaglutide to high standards, but quality varies across the industry. Always verify your platform's compounding pharmacy.

How much weight can I expect to lose on GLP-1 medication?

Clinical trials show average weight loss of 15-22% of body weight over 68-72 weeks with semaglutide (2.4mg) and tirzepatide (15mg). Individual results vary widely. Some patients lose significantly more; others respond modestly. Approximately 10-15% of patients are "non-responders" who do not achieve clinically significant weight loss. Lifestyle factors (diet, exercise, sleep) influence outcomes alongside the medication.

Will I regain weight if I stop taking GLP-1 medication?

The evidence suggests yes. The STEP 1 Trial Extension showed that patients who discontinued semaglutide regained approximately two-thirds of lost weight within one year. This is because GLP-1 medications treat the biological appetite dysregulation that drives weight gain -- when the treatment stops, the biological drivers return. Many patients require long-term or indefinite treatment to maintain weight loss. Discuss a long-term plan with your prescriber.

Can I get Ozempic or Wegovy online?

Brand-name Ozempic and Wegovy can be prescribed through telehealth platforms (Ro, Calibrate, Hims/Hers) if you meet clinical criteria. However, availability is limited by ongoing manufacturer shortages, and insurance coverage is required for affordability ($935-$1,350/month without insurance). Most telehealth patients use compounded semaglutide as the affordable alternative.

Are online GLP-1 platforms safe?

Reputable platforms with proper medical oversight (physician evaluation, lab work, dose titration, monitoring) are generally safe. The risks increase with platforms that prescribe without adequate evaluation, use unverified compounding pharmacies, or start patients at high doses without titration. Choose a platform that requires medical history review, offers physician access for side effect management, and is transparent about their compounding pharmacy partner.

Is insurance needed for GLP-1 medication?

Not necessarily. Compounded semaglutide is available without insurance at $145-$499/month through telehealth platforms. Brand-name medications (Ozempic, Wegovy, Mounjaro, Zepbound) typically require insurance for affordability. Some employer plans and health insurance plans cover GLP-1 medications for weight management (under the Wegovy/Zepbound indication), but coverage varies widely. Check your specific plan's formulary and prior authorization requirements.

Where to Start

• MEDVi -- Start your consultation — Online weight loss clinic with GLP-1 prescriptions starting at competitive prices
• Sprout Health -- Get started — Telehealth weight management with personalized GLP-1 treatment plans
• Elevate Health -- Start your consultation — Personalized GLP-1 weight loss programs with licensed providers
• Yucca Health -- Get started — GLP-1 telehealth with personalized treatment plans
• Eden Health -- Start your consultation — Online weight management with licensed providers
• SkinnyRx -- Get started — GLP-1 weight loss prescriptions online
• DudeMeds -- Start your consultation — Men's telehealth for weight loss, TRT, and more
• Ro (Body Program) -- Start your evaluation
• Calibrate -- Begin your metabolic reset
• Henry Meds -- Get started
• Hims Weight Loss -- Start your consultation
• Found -- Take the health assessment

Prices shown may vary. Links may be affiliate links.

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with significant effects and potential serious side effects including pancreatitis, gallbladder disease, and thyroid tumor risk (boxed warning). Do not start, stop, or change any medication without consulting a qualified healthcare provider. Compounded semaglutide is not FDA-approved and quality varies by pharmacy. The information provided does not replace the expertise of a licensed physician.

Sources: Wilding et al. 2021 (STEP 1 semaglutide, NEJM), Jastreboff et al. 2022 (SURMOUNT-1 tirzepatide, NEJM), Garvey et al. 2022 (STEP 5 semaglutide 2-year, Nature Medicine), Wilding et al. 2022 (STEP 1 extension weight regain, Diabetes Obesity Metabolism), FDA Drug Shortage Database (semaglutide), FDA safety communications on compounded semaglutide. Platform websites and pricing verified at time of publication.

---

Affiliate Disclosure: Freak Naturals may earn a commission on purchases made through links in this article. This does not affect our editorial independence — we recommend products based on research and testing, not commissions.